Antiinflammatory and anticoagulative agents in COVID-19 pneumonia treatment
Not Applicable
- Conditions
- Completed
- Registration Number
- JPRN-UMIN000042489
- Lead Sponsor
- I.M. Sechenov First Moscow State Medical University (Sechenov University) Pulmonology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 157
Inclusion Criteria
Not provided
Exclusion Criteria
Dexamethasone intake for prior 6 month, anti-interleukin drugs admission
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dexamethasone therapy in SARS-CoV-2 patients significantly improved CT score and appear to decrease mortality rate.
- Secondary Outcome Measures
Name Time Method